Pricing Log in Create free account
Saturday 17 October 2026 Export A’s income statement to Excel — free account

Agilent Technologies, Inc.

A Healthcare Diagnostics & Research

Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

172.96 2.59 −1.48%
Market cap
$49.5B
P/E
34.0×
Fwd P/E
26.3×
Dividend yield
0.59%
F-score
5/9
Altman Z
5.46
Beneish M
−2.46
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Agilent Technologies, Inc. (A) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Sep 2, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits Officer departure
10-Q Jul 31, 2026 P1I2: 16 added · 12 removed · 69 modified
P2I1A: 16 modified
8-K Aug 26, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 25, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
10-Q Apr 30, 2026
8-K May 20, 2026 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
8-K May 4, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K/A Mar 31, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
8-K Mar 31, 2026 5.01 Change in control; 9.01 Financial statements and exhibits
8-K Mar 18, 2026 5.03 Amendments to the articles or bylaws; change in fiscal year; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits
8-K Mar 5, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
10-Q Jan 31, 2026
8-K Feb 25, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Oct 31, 2025 1: 22 added · 19 removed · 61 modified
1A: 8 added · 6 removed · 37 modified
7: 29 added · 32 removed · 89 modified
8-K Nov 24, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 23, 2025 5.02 Departure or appointment of directors or officers
10-Q Jul 31, 2025
8-K Aug 27, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Oct 31, 2024

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.